Olivier Nolan-Stevaux

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Replacement Therapy

Top Venues

Science translational medicine

Cancer discovery

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Olivier Nolan-Stevaux, Cong Li, Lingming Liang, Jinghui Zhan, Juan Estrada, Tao Osgood, Fei Li, Hanzhi Zhang, Ryan Case, Christopher M Murawsky, Bram Estes, Gregory L Moore, Matthew J Bernett, Umesh S Muchhal, John R Desjarlais, Binnaz K Staley, Jennitte L Stevens, Keegan S Cooke, Famke Aeffner, Oliver Thomas, Julia Stieglmaier, Jae Lyun Lee, Angela Coxon, Julie M Bailis
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer. Cancer discovery (2023)
Ye Shen, Jason S Eng, Flordeliza Fajardo, Lingming Liang, Cong Li, Patrick Collins, Donato Tedesco, Olivier Nolan-Stevaux
Cancer cell-intrinsic resistance to BiTE therapy is mediated by loss of CD58 costimulation and modulation of the extrinsic apoptotic pathway. Journal for immunotherapy of cancer 10 (3) (2022)
Brian Belmontes, Deepali V Sawant, Wendy Zhong, Hong Tan, Anupurna Kaul, Famke Aeffner, Sarah A O'Brien, Matthew Chun, Rajkumar Noubade, Jason Eng, Hayley Ma, Markus Muenz, Peng Li, Benjamin M Alba, Melissa Thomas, Kevin D Cook, Xiaoting Wang, Jason DeVoss, Jackson G Egen, Olivier Nolan-Stevaux
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell-cold solid tumors. Science translational medicine 13 (608) (2021)